Protagonist Therapeutics Inc (PTGX)

Exchange
NASDAQ
Symbol
PTGX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.
Country
USA

Stock price

At close: February 5, 2026

  • Open
    83.62
  • High
    85.43
  • Low
    80.20
  • Close
    80.67
  • Volume
    457,064

Financial ratios

Dec 31, 2024